Middle East Conflict Threatens ₹5,000 Crore in Indian Pharma Exports

Rising tensions in the Middle East are threatening Indian pharmaceutical exports worth up to ₹5,000 crore. Shipping disruptions, rising freight costs, and unstable maritime routes could impact medicine supply to Gulf countries. The situation highlights the vulnerability of global pharma supply chains and the importance of stable trade routes.